GP73、AFP 异质体联合检测在原发性肝癌早期诊断中的应用进展(3)
[7] Hu JS，Wu DW，Liang S，et al.GP73，a resident Golgi glycoprotein，is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population[J].Med Oncol，2010，27(2)：339-345.
[8] 李淑群，陈谦，喻亚群，等.肝细胞肝癌组织中GP73的表达变化[J].山东医药，2011，51(2)：60-61.
[9] 石玉玲，曾兰兰，李林海，等.高尔基体蛋白73及其基因检测对原发性肝癌诊断的价值[J].中华检验医学杂志， 2010，33(6)：507-512.
[10] Miura N，Osaki Y，Nagashima M，et al.A novel biomarker TERTm-RNA is applicable for early detection of hepatoma[J].BMC Gastroenterol，2010，10：46.
[11] Tangkijvanich P，Chanmee T，Komtong S，et al.Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers[J].J Gastroenterol Hepatol，2010，25(1)：129-137.
[12] Liu Y，He J，Li C，et al.Identification and confinnation of biomarkers using an intergrated platform for quantitative analysis of glycoproteins and their glycosylations[J].J Proteome Res，2010，9(2)：798-805.
[13] Chignard N，Shang S，Wang H，et al.Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma：detection of generaled fragments in patient sera[J].Gastroenterology，2006，130(7)：2010-2022.
[14] Kudo M.The 2008 Okuda lecture：management of hepatocellular carcinoma：from surveillance to molecular targeted therapy[J].J Gastroenterol Hepatol，2010，25(3)：439-452.
[15] Sangro B，Carpanese L，Cianni R，et al.Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages：a European evaluation[J].Hepatology，2011，54(3)：868-878.
[16] Giannelli G，Mazzocca A，Fransvea E，et al.Inhibiting TGF-β signaling in hepatocellular carcinoma[J].Biochim Biophys Acta，2011，1815(2)：214-223.
[17] Maniya T，Yamazaki K，Masugi Y，et al.Reduced transforming growth factor-beta receptor Ⅱ expression in hepatocellular carcinoma correlates with intrahepatic metastasis[J].Lab Invest，2010，90(9)：1339-1345.
[18] Siegel R，Naishhadham D，Jemal A.Cancer statistics，2012[J].CA Cancer J Clin，2012，62(1)：10-29.
[19] Blechacz B，Mishra L.Hepatocellular carcinoma biology[J].Recent Results Cancer Res，2013，190：1-20.
[20] European Association for the Study of the Liver.EASL Clinical Practice Guidelines：management of cholestatic liver diseases[J].J Hepatol，2009，51(2)：237-267.
[21] Abu El Makarem M.An overview of biomarkers for the diagnosis of hepatocellular carcinoma[J].Hepat Mon，2012， 12(10 HCC)：e6122.
[22] 杨华瑜，王绎沈，徐海峰，等.血清AFP.GP73.GPC3 单独及联合检测对肝癌的诊断价值[J].癌症进展，2013，11(3)：249-253.
[23] 杨贵敏，杨运强，赵云胜.血清异常凝血酶原，磷脂酰肌醇蛋白聚糖-3联合甲胎蛋白检测在原发性肝癌诊断中的临床意义[J].山西医药杂志，2013，42(7)：783-785.
[24] 龙璐，陈贞，王堃，等.血清GP73、GPC3、AFP-L3和AFP检测对原发性肝癌诊断的价值[J].中国现代医学杂志，2013，23(28)：46-50.
[25] Ozkan H，Erdal H，Kocak E，et al.Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma[J].J Clin Lab Anal，2011，25(5)：350-353.
[26] Qiao SS，CuiZQ，Gong L，et al.Simultaneous measurements of serum AFP，GPC-3 and HCCR for diagnosing hepatocellular carcinoma[J].Hepatogastroenterology，2011，58(110-111)：1718-1724.
(收稿日期：2014-10-21 本文编辑：许俊琴) (周亮 王世明)
[8] 李淑群，陈谦，喻亚群，等.肝细胞肝癌组织中GP73的表达变化[J].山东医药，2011，51(2)：60-61.
[9] 石玉玲，曾兰兰，李林海，等.高尔基体蛋白73及其基因检测对原发性肝癌诊断的价值[J].中华检验医学杂志， 2010，33(6)：507-512.
[10] Miura N，Osaki Y，Nagashima M，et al.A novel biomarker TERTm-RNA is applicable for early detection of hepatoma[J].BMC Gastroenterol，2010，10：46.
[11] Tangkijvanich P，Chanmee T，Komtong S，et al.Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers[J].J Gastroenterol Hepatol，2010，25(1)：129-137.
[12] Liu Y，He J，Li C，et al.Identification and confinnation of biomarkers using an intergrated platform for quantitative analysis of glycoproteins and their glycosylations[J].J Proteome Res，2010，9(2)：798-805.
[13] Chignard N，Shang S，Wang H，et al.Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma：detection of generaled fragments in patient sera[J].Gastroenterology，2006，130(7)：2010-2022.
[14] Kudo M.The 2008 Okuda lecture：management of hepatocellular carcinoma：from surveillance to molecular targeted therapy[J].J Gastroenterol Hepatol，2010，25(3)：439-452.
[15] Sangro B，Carpanese L，Cianni R，et al.Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages：a European evaluation[J].Hepatology，2011，54(3)：868-878.
[16] Giannelli G，Mazzocca A，Fransvea E，et al.Inhibiting TGF-β signaling in hepatocellular carcinoma[J].Biochim Biophys Acta，2011，1815(2)：214-223.
[17] Maniya T，Yamazaki K，Masugi Y，et al.Reduced transforming growth factor-beta receptor Ⅱ expression in hepatocellular carcinoma correlates with intrahepatic metastasis[J].Lab Invest，2010，90(9)：1339-1345.
[18] Siegel R，Naishhadham D，Jemal A.Cancer statistics，2012[J].CA Cancer J Clin，2012，62(1)：10-29.
[19] Blechacz B，Mishra L.Hepatocellular carcinoma biology[J].Recent Results Cancer Res，2013，190：1-20.
[20] European Association for the Study of the Liver.EASL Clinical Practice Guidelines：management of cholestatic liver diseases[J].J Hepatol，2009，51(2)：237-267.
[21] Abu El Makarem M.An overview of biomarkers for the diagnosis of hepatocellular carcinoma[J].Hepat Mon，2012， 12(10 HCC)：e6122.
[22] 杨华瑜，王绎沈，徐海峰，等.血清AFP.GP73.GPC3 单独及联合检测对肝癌的诊断价值[J].癌症进展，2013，11(3)：249-253.
[23] 杨贵敏，杨运强，赵云胜.血清异常凝血酶原，磷脂酰肌醇蛋白聚糖-3联合甲胎蛋白检测在原发性肝癌诊断中的临床意义[J].山西医药杂志，2013，42(7)：783-785.
[24] 龙璐，陈贞，王堃，等.血清GP73、GPC3、AFP-L3和AFP检测对原发性肝癌诊断的价值[J].中国现代医学杂志，2013，23(28)：46-50.
[25] Ozkan H，Erdal H，Kocak E，et al.Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma[J].J Clin Lab Anal，2011，25(5)：350-353.
[26] Qiao SS，CuiZQ，Gong L，et al.Simultaneous measurements of serum AFP，GPC-3 and HCCR for diagnosing hepatocellular carcinoma[J].Hepatogastroenterology，2011，58(110-111)：1718-1724.
(收稿日期：2014-10-21 本文编辑：许俊琴) (周亮 王世明)